Engerix B

Engerix B is a vaccine designed to prevent hepatitis B, a viral infection affecting the liver. This recombinant DNA vaccine stimulates the immune system to produce antibodies against the hepatitis B virus. It is suitable for adults and children, offering protection through intramuscular or subcutaneous administration.

Engerix B is primarily used to prevent hepatitis B infection. This vaccine is recommended for individuals at risk of exposure to the virus, such as healthcare workers, travelers to regions with high hepatitis B prevalence, and those with chronic liver disease. It is also used for newborns whose mothers are hepatitis B surface antigen-positive. The vaccine works by triggering the body's immune response to produce antibodies against the hepatitis B virus, providing long-term protection.

Common effects of Engerix B may include soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve within a few days. Severe allergic reactions are rare but can occur and require immediate medical attention.

Engerix B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to yeast or any component of the vaccine should avoid it. Pregnant or breastfeeding women should consult their healthcare provider before receiving the vaccine. It is important to inform the healthcare provider about any current illnesses or medications being taken.

Engerix B may interact with certain medications that affect the immune system. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Alcohol consumption does not typically interact with the vaccine, but maintaining overall health is recommended. Specific interactions with other vaccines should be discussed with a healthcare professional.